Operating Income: The income after operating expenses.
Climb Bio, Inc. (CLYM) had Operating Income of $-14.89M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-12.89M |
|
-- |
|
-- |
|
$14.89M |
|
|
Operating Income |
$-14.89M |
$2.00M |
|
$-12.89M |
|
$-12.89M |
|
$-12.89M |
|
$-12.89M |
|
$-12.89M |
|
$-12.89M |
|
$-14.89M |
|
$-15.39M |
|
68.00M |
|
68.00M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$90.96M |
|
$0.32M |
|
$91.34M |
|
$182.30M |
|
$4.95M |
|
-- |
|
$0.35M |
|
$5.30M |
|
$177.00M |
|
$177.00M |
|
$177.00M |
|
68.18M |
|
| Cash Flow Statement Financials | |
$-38.72M |
|
$-22.70M |
|
-- |
|
$87.23M |
|
$25.80M |
|
$-61.43M |
|
$7.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.38 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-38.91M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.28% |
|
-7.28% |
|
-7.07% |
|
-7.28% |
|
$2.60 |
|
$-0.57 |
|
$-0.57 |
|